To include your compound in the COVID-19 Resource Center, submit it here.

Daily Chart: COVID-19 programs still growing

BioCentury is providing this content for free given the urgent need for information about the coronavirus crisis. Further analysis can be found in our COVID-19 Resource Center. For more, sign up for our daily email.

New products continue to enter the COVID-19 pipeline. BioCentury is now tracking 457 therapeutics and vaccines in preclinical or clinical development.

Among the therapeutic candidates, over 100 could interfere directly in viral invasion or replication (see “COVID-19 Pipeline: Spotlight on Strategies to Block Viral Entry or Replication”).

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers